Abstract
Chlamydophila felis (C. felis), feline herpesvirus-1 (FHV-1), and feline calicivirus (FCV) were detected in 39 (59.1%), 11 (16.7%), and 14 (21.2%) cats, respectively, from 66 domestic cats presented with conjunctivitis and upper respiratory tract disease (URTD) in Japan. Dual and multiple infections were common, involving combinations of all three agents. While genetic analysis of the Major Outer Membrane Protein (MOMP) showed high conservation, antigenic differences were identified in a 96 kDa protein of Japanese isolates compared to the US Fe/145 strain. These findings suggest that C. felis is the primary agent of feline respiratory disease in Japan and highlight regional antigenic variations.
Introduction
Upper respiratory tract disease (URTD) and conjunctivitis represent significant clinical challenges in feline medicine. These conditions are typically caused by a complex of pathogens, most notably Feline Herpesvirus-1 (FHV-1), Feline Calicivirus (FCV), and the bacterium Chlamydophila felis. While these agents are recognized globally, their specific prevalence and the dynamics of co-infection can vary by geographic region.
In Japan, the epidemiological role of C. felis—particularly in the context of viral co-infections—has historically been under-reported. This study aimed to investigate the prevalence of these pathogens across multiple Japanese prefectures and to determine if local strains of C. felis exhibit genetic or antigenic divergence from standard international reference strains, such as the US-derived Fe/145.
Methodology
The researchers collected samples from 66 domestic cats exhibiting clinical signs of URTD or conjunctivitis across nine Japanese prefectures between 1998 and 2000. Detection of C. felis and FHV-1 was performed via PCR, while FCV was detected using RT-PCR. To assess the viability of the pathogens, isolation was attempted using yolk sac inoculation for C. felis and cell culture (CRFK and SL cells) for the viruses.
Molecular characterization involved sequencing the Major Outer Membrane Protein (MOMP) gene. Antigenic profiles were analyzed using SDS-PAGE and Western blotting, employing anti-Fe/145 antiserum to compare Japanese isolates with the standard US reference strain.
Results: Prevalence and Regional Distribution
The study identified C. felis as the most prevalent pathogen, detected in 59.1% (39/66) of the symptomatic cats. FCV and FHV-1 were detected in 21.2% and 16.7% of cases, respectively. Interestingly, there was a significant "isolation gap" for C. felis; while 39 cats were PCR-positive, the bacterium was successfully isolated from only 11 (28.2%) of those cases. This discrepancy may be attributed to the fragility of the organism during transport or the presence of non-viable bacterial DNA.
Pathogen Co-infections and Clinical Symptoms
The "feline respiratory complex" was evident in the high rate of co-infections. Over 25% of the cats were infected with C. felis alongside at least one viral agent. Specifically, dual infections of C. felis and FCV occurred in 15.2% of the cohort, while C. felis and FHV-1 co-occurred in 10.6%. One cat was found to be infected with all three pathogens simultaneously. These findings underscore the importance of multi-pathogen screening in clinical feline medicine.
Antigenic and Genetic Characterization
A key finding of this research was the divergence between genetic and antigenic profiles. Sequencing revealed that the MOMP gene of the Japanese isolates was identical to the US Fe/145 strain. However, Western blot analysis using anti-Fe/145 antiserum revealed a distinct difference in a 96 kDa protein.
As shown in the Western blot, the Japanese isolates (lanes 1-5) reacted strongly at the 96 kDa mark, whereas the US reference strain typically shows weaker reactivity at this weight. This suggests that while major structural proteins like MOMP remain conserved, other immunogenic proteins vary significantly by region, which could have implications for vaccine cross-protection.
Discussion and Future Directions
This investigation confirms that C. felis is a primary driver of feline conjunctivitis and URTD in Japan. The discovery of antigenic variation in the 96 kDa protein, despite genetic conservation of the MOMP gene, suggests that current vaccines based on international strains may require regional optimization.
Limitations of the study include a relatively small sample size (n=66) and the exclusion of other potential pathogens like Bordetella bronchiseptica or Mycoplasma. Future research should focus on the functional role of the 96 kDa protein and broader epidemiological surveys to better inform feline vaccination strategies in Japan.
Summary updated